Heron Therapeutics (HRTX) Quick Ratio: History & Chart

Heron Therapeutics, Inc.(HRTX)

Biotechnology · Cary, NC

$0.33-0.04 (-10.35%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concentrations are maintained for periods ranging from days to weeks following just a single administration. Among its commercialized products is SUSTOL (granisetron), an extended-release injectable designed to prevent both immediate and delayed nausea and vomiting triggered by moderately emetogenic chemotherapy, or specific anthracycline and cyclophosphamide combination therapies. Additionally, Heron markets CINVANTI, an intravenous formulation of aprepitant. CINVANTI, which acts as a substance P/neurokinin-1 receptor antagonist, is indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients undergoing highly or moderately emetogenic cancer chemotherapy. The company's development pipeline includes ZYNRELEF, an innovative dual-acting local anesthetic that combines bupivacaine, a local anesthetic, with a low dose of the nonsteroidal anti-inflammatory drug (NSAID) meloxicam in a single fixed-dose formulation. Also in development is HTX-019, an experimental therapy aimed at preventing postoperative nausea and vomiting (PONV). Furthermore, HTX-034 is being advanced for postoperative pain management and is currently undergoing Phase Ib/II clinical trials, notably in patients recovering from bunionectomy procedures. Originally established in 1983 as A.P. Pharma, Inc., the company adopted its current name, Heron Therapeutics, Inc., in January 2014. Its corporate headquarters are situated in San Diego, California.

Cary, NC

128 employees

www.herontx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Craig Alexander Collard

View full financials

HRTX Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

1.51

QUICK RATIO (ACID-TEST) AVG TTM

1.37

QUICK RATIO (ACID-TEST) AVG 3Y

1.70

QUICK RATIO (ACID-TEST) AVG 5Y

1.69

QUICK RATIO (ACID-TEST) AVG 10Y

2.57

QUICK RATIO (ACID-TEST) AVG 15Y

3.91

QUICK RATIO (ACID-TEST) AVG 20Y

3.87

CURRENT VS TTM AVG

+10.46%

CURRENT VS 3Y AVG

-11.12%

CURRENT VS 5Y AVG

-10.42%

CURRENT VS 10Y AVG

-41.28%

CURRENT VS 15Y AVG

-61.35%

CURRENT VS 20Y AVG

-60.94%

SECTOR MEDIAN · HEALTHCARE

3.35

median of 870 covered companies

CURRENT VS SECTOR MEDIAN

-54.95%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Heron Therapeutics, Inc. (HRTX)	$62.78M	1.51	1.37	1.70	1.69
RenovoRx, Inc. (RNXT)vs ›	$62.62M	5.53	4.01	3.97	5.62
InterCure Ltd. (INCR)vs ›	$63.02M	0.97	1.07	1.19	1.33
Pliant Therapeutics, Inc. (PLRX)vs ›	$63.78M	9.90	11.46	13.71	15.39
Alps Group Inc (ALPS)vs ›	$64.18M	0.27	0.22	0.21	0.99
Fractyl Health, Inc. (GUTS)vs ›	$60.42M	3.15	4.21	4.66	4.26
Oncolytics Biotech Inc. (ONCY)vs ›	$60.02M	1.35	1.97	5.50	8.52
XBiotech Inc. (XBIT)vs ›	$65.85M	33.15	13.79	28.68	44.67
Cingulate Inc. (CING)vs ›	$65.86M	3.50	1.85	1.22	3.58
Gossamer Bio, Inc. (GOSS)vs ›	$65.87M	0.53	4.76	5.20	7.10

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Heron Therapeutics, Inc. (HRTX)

$62.78M

1.51

1.37

1.70

1.69

RenovoRx, Inc. (RNXT)vs ›

$62.62M

5.53

4.01

3.97

5.62

InterCure Ltd. (INCR)vs ›

$63.02M

0.97

1.07

1.19

1.33

Pliant Therapeutics, Inc. (PLRX)vs ›

$63.78M

9.90

11.46

13.71

15.39

Alps Group Inc (ALPS)vs ›

$64.18M

0.27

0.22

0.21

0.99

Fractyl Health, Inc. (GUTS)vs ›

$60.42M

3.15

4.21

4.66

4.26

Oncolytics Biotech Inc. (ONCY)vs ›

$60.02M

1.35

1.97

5.50

8.52

XBiotech Inc. (XBIT)vs ›

$65.85M

33.15

13.79

28.68

44.67

Cingulate Inc. (CING)vs ›

$65.86M

3.50

1.85

1.22

3.58

Gossamer Bio, Inc. (GOSS)vs ›

$65.87M

0.53

4.76

5.20

7.10

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Heron Therapeutics, Inc. (HRTX)?

The quick ratio (acid-test) for HRTX stock is 1.51.

Is Heron Therapeutics, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 1.51 is 10% below its 5-year average of 1.69, near the low end of its 5-year range (0.53–3.94).

What is the TTM average quick ratio (acid-test) for Heron Therapeutics, Inc. (HRTX)?

The TTM average quick ratio (acid-test) for HRTX stock is 1.37.

What is the 3Y average quick ratio (acid-test) for Heron Therapeutics, Inc. (HRTX)?

The 3Y average quick ratio (acid-test) for HRTX stock is 1.70.

What is the 5Y average quick ratio (acid-test) for Heron Therapeutics, Inc. (HRTX)?

The 5Y average quick ratio (acid-test) for HRTX stock is 1.69.

What is the 10Y average quick ratio (acid-test) for Heron Therapeutics, Inc. (HRTX)?

The 10Y average quick ratio (acid-test) for HRTX stock is 2.57.

What is the 15Y average quick ratio (acid-test) for Heron Therapeutics, Inc. (HRTX)?

The 15Y average quick ratio (acid-test) for HRTX stock is 3.91.

What is the 20Y average quick ratio (acid-test) for Heron Therapeutics, Inc. (HRTX)?

The 20Y average quick ratio (acid-test) for HRTX stock is 3.87.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	1.51
2026-03-31	1.51
2025-12-31	1.51
2025-09-30	1.78
2025-06-30	0.53
2025-03-31	1.76
2024-12-31	1.70
2024-09-30	1.74
2024-06-30	1.85
2024-03-31	1.90
2023-12-31	1.84
2023-09-30	1.91
2023-06-30	1.39
2023-03-31	1.62
2022-12-31	1.83
2022-09-30	1.83
2022-06-30	1.21
2022-03-31	1.79
2021-12-31	2.90
2021-09-30	3.78
2021-06-30	3.94
2021-03-31	2.28
2020-12-31	2.66
2020-09-30	3.16
2020-06-30	3.79
2020-03-31	4.17
2019-12-31	4.70
2019-09-30	3.51
2019-06-30	3.70
2019-03-31	4.06
2018-12-31	4.44
2018-09-30	6.69
2018-06-30	6.04
2018-03-31	1.72
2017-12-31	2.11
2017-09-30	2.02
2017-06-30	2.72
2017-03-31	4.79
2016-12-31	1.47
2016-09-30	2.97
2016-06-30	2.79
2016-03-31	5.50
2015-12-31	6.83
2015-09-30	9.42
2015-06-30	10.45
2015-03-31	4.86
2014-12-31	5.41
2014-09-30	7.92
2014-06-30	9.78
2014-03-31	8.09
2013-12-31	10.43
2013-09-30	4.25
2013-06-30	3.67
2013-03-31	6.08
2012-12-31	13.02
2012-09-30	14.23
2012-06-30	4.17
2012-03-31	4.09
2011-12-31	4.94
2011-09-30	8.39
2011-06-30	6.81
2011-03-31	0.89
2010-12-31	1.60
2010-09-30	2.65
2010-06-30	2.42
2010-03-31	4.15
2009-12-31	4.41
2009-09-30	0.96
2009-06-30	1.65
2009-03-31	2.80
2008-12-31	3.39
2008-09-30	2.97
2008-06-30	4.33
2008-03-31	5.15
2007-12-31	5.77
2007-09-30	11.46
2007-06-30	12.90
2007-03-31	2.68
2006-12-31	3.87
2006-09-30	7.81
2006-06-30	9.71
2006-03-31	12.00
2005-12-31	2.77
2005-09-30	3.92
2005-06-30	4.77
2005-03-31	6.91
2004-12-31	5.42
2004-09-30	7.54
2004-06-30	10.04
2004-03-31	3.82
2003-12-31	5.95
2003-09-30	6.29
2003-06-30	6.46
2003-03-31	6.64
2002-12-31	7.97
2002-09-30	6.75

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

1.51

2026-03-31

1.51

2025-12-31

1.51

2025-09-30

1.78

2025-06-30

0.53

2025-03-31

1.76

2024-12-31

1.70

2024-09-30

1.74

2024-06-30

1.85

2024-03-31

1.90

2023-12-31

1.84

2023-09-30

1.91

2023-06-30

1.39

2023-03-31

1.62

2022-12-31

1.83

2022-09-30

1.83

2022-06-30

1.21

2022-03-31

1.79

2021-12-31

2.90

2021-09-30

3.78

2021-06-30

3.94

2021-03-31

2.28

2020-12-31

2.66

2020-09-30

3.16

2020-06-30

3.79

2020-03-31

4.17

2019-12-31

4.70

2019-09-30

3.51

2019-06-30

3.70

2019-03-31

4.06

2018-12-31

4.44

2018-09-30

6.69

2018-06-30

6.04

2018-03-31

1.72

2017-12-31

2.11

2017-09-30

2.02

2017-06-30

2.72

2017-03-31

4.79

2016-12-31

1.47

2016-09-30

2.97

2016-06-30

2.79

2016-03-31

5.50

2015-12-31

6.83

2015-09-30

9.42

2015-06-30

10.45

2015-03-31

4.86

2014-12-31

5.41

2014-09-30

7.92

2014-06-30

9.78

2014-03-31

8.09

2013-12-31

10.43

2013-09-30

4.25

2013-06-30

3.67

2013-03-31

6.08

2012-12-31

13.02

2012-09-30

14.23

2012-06-30

4.17

2012-03-31

4.09

2011-12-31

4.94

2011-09-30

8.39

2011-06-30

6.81

2011-03-31

0.89

2010-12-31

1.60

2010-09-30

2.65

2010-06-30

2.42

2010-03-31

4.15

2009-12-31

4.41

2009-09-30

0.96

2009-06-30

1.65

2009-03-31

2.80

2008-12-31

3.39

2008-09-30

2.97

2008-06-30

4.33

2008-03-31

5.15

2007-12-31

5.77

2007-09-30

11.46

2007-06-30

12.90

2007-03-31

2.68

2006-12-31

3.87

2006-09-30

7.81

2006-06-30

9.71

2006-03-31

12.00

2005-12-31

2.77

2005-09-30

3.92

2005-06-30

4.77

2005-03-31

6.91

2004-12-31

5.42

2004-09-30

7.54

2004-06-30

10.04

2004-03-31

3.82

2003-12-31

5.95

2003-09-30

6.29

2003-06-30

6.46

2003-03-31

6.64

2002-12-31

7.97

2002-09-30

6.75

Quick Ratio (Acid-Test): 1.51

HRTX Quick Ratio

HRTX Average Quick Ratio (Acid-Test) Chart

HRTX Current vs Average Quick Ratio (Acid-Test) Chart

HRTX Quick Ratio (Acid-Test) Metrics

HRTX Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

HRTX Quick Ratio (Acid-Test) History

Related Metrics